When do appetite changes usually begin
free in non-Quest states Outcome 4: Treatment Not Recommended If provider determines GLP-1 medication is not medically appropriate: Provider documents reasons for decision (may include contraindications, insufficient medical justification, alternative treatment recommendations) Member receives notification with explanation According to ro.co, members who are not approved receive full refund of any membership fees paid Member not enrolled in ongoing subscription program Provider may suggest alternative weight management approaches or recommend follow-up with primary care physician Review Timeline : According to ro.co, providers complete assessment review within 48 hours under normal circumstances (business days only
Molin MD, Kim H, Blackford A, Sharma R, Goggins M
Nausea, vomiting, diarrhea, constipation, reflux, and reduced appetite can occur with incretin-based therapies
Educating patients about their treatment encourages active participation
Staying informed through reputable sources including the NHS website, NICE, and the MHRA is strongly encouraged as the evidence base for retatrutide continues to evolve
